Log in to your Inderes Free account to see all free content on this page.
FluoGuide
41.75 SEK -5.11%HC Andersen Capital has previously received payment from FluoGuide for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
6 investors are following this company
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUO
Daily low / high price
41 / 43.1
SEK
Market cap
568.64M SEK
Turnover
1.21M SEK
Volume
29K
Latest videos
Financial calendar
Interim report
29.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Life Science IVS | 17.4 % | 17.4 % |
Wexotec ApS | 12.2 % | 12.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
FluoGuide intends to carry out a directed share issue of approximately SEK 60 million
Redeye: Fluoguide Q1 2024 - Preparing for next steps
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
FluoGuide A/S publishes interim report for the period January – March 2024
FluoGuide selects laser system for photothermal cancer therapy with FG001
![Fluoguide: Wrap up from interview with CEO Morten Albrechtsen](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/80e5ec49-e4de-4ab9-b18e-f9051fc68ce3.png)
Fluoguide: Wrap up from interview with CEO Morten Albrechtsen
Minutes from Annual General Meeting in FluoGuide A/S
![HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/06aef4ac-f94b-407d-ac4d-dffe67b0f7a5.png)
HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.
Chief Financial Officer (CFO) Ole Larsen buys shares
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company
![Fluoguide: Wrap up from introduction to the company](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/4512dd49-f2aa-4490-981c-14b5bc354847.png)
Fluoguide: Wrap up from introduction to the company
Notice of Annual General Meeting in FluoGuide A/S
Redeye: Fluoguide Q4 2023 - Bright prospects
![Introduction to FluoGuide](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/80e5ec49-e4de-4ab9-b18e-f9051fc68ce3.png)